Kevin Krenitsky, MD, was named president of the Exzo Clinical Labs subsidiary of Enzo Biochem (New York). Prior to joining Enzo Clinical Labs, Krenitsky was CEO of Bioserve Biotechnologies. Enzo Biochem makes products and technologies based on molecular biology and genetic engineering techniques, and in providing diagnostic services.

No Comments